Stock Analysis
- United Kingdom
- /
- Chemicals
- /
- LSE:GPL
Graft Polymer (UK) Full Year 2023 Earnings: UK£0.03 loss per share (vs UK£0.026 loss in FY 2022)
Graft Polymer (UK) (LON:GPL) Full Year 2023 Results
Key Financial Results
- Revenue: UK£587.0k (up 8.3% from FY 2022).
- Net loss: UK£3.12m (loss widened by 15% from FY 2022).
- UK£0.03 loss per share (further deteriorated from UK£0.026 loss in FY 2022).
All figures shown in the chart above are for the trailing 12 month (TTM) period
The primary driver behind last 12 months revenue was the Europe segment contributing a total revenue of UK£355.0k (60% of total revenue). Notably, cost of sales worth UK£446.0k amounted to 76% of total revenue thereby underscoring the impact on earnings. The largest operating expense was General & Administrative costs, amounting to UK£2.36m (72% of total expenses). Explore how GPL's revenue and expenses shape its earnings.
Graft Polymer (UK) shares are down 14% from a week ago.
Risk Analysis
Before we wrap up, we've discovered 6 warning signs for Graft Polymer (UK) (5 are concerning!) that you should be aware of.
Valuation is complex, but we're helping make it simple.
Find out whether Graft Polymer (UK) is potentially over or undervalued by checking out our comprehensive analysis, which includes fair value estimates, risks and warnings, dividends, insider transactions and financial health.
View the Free AnalysisHave feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
About LSE:GPL
Graft Polymer (UK)
Researches and develops polymer modification technologies and techniques in the United Kingdom, Slovenia, and Europe.
Excellent balance sheet medium.